Table 1.

Study Population Denominators and Outcomes by Cancer Site and Age Group

Cancer site	Age (at Diagnosis), y	Individuals	Female	Years of Follow-Up From Indexa	Deaths
					Cardiovascular	Primary Malignancy	All Malignancies
All	67.7 ± 11.9	104,028	52,713 (50.7)	4.8 (2.0-8.7)	7,091	19,758	25,666
Bladder (C67)	40-59	1,288	324 (25.2)	7.7 (3.9-11.9)	32	99	172
	60-79	5,640	1,230 (21.8)	5.3 (2.4-9.1)	598	714	1,316
	≥80	2,080	594 (28.6)	3.1 (1.3-5.7)	367	384	600
Breast (C50)	40-59	12,208	12,208 (100.0)	7.1 (3.6-11.4)	88	1,486	1,713
	60-79	12,669	12,669 (100.0)	6.1 (3.0-9.9)	661	1,701	2,304
	≥80	3,793	3,793 (100.0)	3.2 (1.4-5.9)	646	879	1,064
Colorectal (C18-C20)	40-59	3,029	1,364 (45.0)	5.4 (2.0-10.1)	29	690	856
	60-79	10,029	4,125 (41.1)	4.6 (1.9-8.5)	638	2,189	3,057
	≥80	3,471	1,881 (54.2)	2.9 (1.0-5.8)	500	948	1,304
Leukemia (C91-C95)	40-59	903	344 (38.1)	5.8 (2.7-9.6)	16	168	198
	60-79	2,217	885 (39.9)	4.7 (2.0-8.0)	151	489	664
	≥80	759	371 (48.9)	2.6 (1.0-5.3)	114	177	234
Lung (C34)	40-59	1,044	510 (48.9)	1.5 (0.5-5.2)	25	593	631
	60-79	4,102	1,723 (42.0)	1.3 (0.5-3.9)	183	2,373	2,544
	≥80	1,016	504 (49.6)	0.9 (0.4-2.2)	93	607	646
Melanoma (C43)	40-59	2,850	1,673 (58.7)	6.9 (3.4-10.8)	12	200	256
	60-79	3,396	1,684 (49.6)	5.4 (2.5-9.2)	197	358	556
	≥80	1,030	599 (58.2)	3.1 (1.3-5.9)	158	122	229
NHL (C82-C85)	40-59	1,450	622 (42.9)	6.4 (3.0-10.6)	25	200	263
	60-79	2,674	1,293 (48.4)	4.8 (2.1-8.1)	203	535	718
	≥80	721	418 (58.0)	2.9 (1.3-5.1)	114	188	250
Prostate (C61)	40-59	2,341	0 (0.0)	5.8 (2.9-9.4)	29	229	264
	60-79	16,742	0 (0.0)	5.1 (2.5-8.5)	1,182	2,647	3,533
	≥80	4,677	0 (0.0)	2.9 (1.3-5.1)	818	1,271	1,560
Uterus (C54-C55)	40-59	1,133	1,133 (100.0)	7.2 (3.6-11.2)	18	88	128
	60-79	2,328	2,328 (100.0)	5.5 (2.4-9.2)	120	325	473
	≥80	438	438 (100.0)	3.5 (1.2-6.0)	74	98	133

Values are mean ± SD, n, n (%), or median (IQR).

NHL = non-Hodgkin lymphoma.

^a1 year following cancer diagnosis.